Enhanced Antitumor Immune Responses via a Self-Assembled Carrier-Free Nanovaccine
Dan Liu,Bo Deng,Zongran Liu,Bing Ma,Xigang Leng,Deling Kong,Tianjiao Ji,Lanxia Liu
DOI: https://doi.org/10.1021/acs.nanolett.1c00648
IF: 10.8
2021-04-22
Nano Letters
Abstract:Nanovaccines have emerged as promising agents for cancer immunotherapy. However, insufficient antitumor immunity caused by inefficient antigen/adjuvant loading and complicated preparation processes are the major obstacles that limit their clinical application. Herein, two adjuvants, monophosphatidyl A (MPLA) and CpG ODN, with antigens were designed into a nanovaccine to overcome the above obstacles. This nanovaccine was constructed with adjuvants (without additional materials) through facile self-assembly, which not only ensured a high loading efficacy and desirable safety but also facilitated clinical translation for convenient fabrication. More importantly, the selected adjuvants could achieve a notable immune response through synergistic activation of Toll-like receptor 4 (TLR4) and TLR9 signaling pathways, and the resulting nanovaccine remarkably inhibited the tumor growth and prolonged the survival of tumor-implanted mice. This nanovaccine system provides an effective strategy to construct vaccines for cancer immunotherapy.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.nanolett.1c00648?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.nanolett.1c00648</a>.Materials and methods and additional results as presented in Figures S1–S13 and Table S1 (<a class="ext-link" href="/doi/suppl/10.1021/acs.nanolett.1c00648/suppl_file/nl1c00648_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology